Kawano Y
Department of Pediatrics, School of Medicine, University of Tokushima.
Rinsho Ketsueki. 1990 May;31(5):655-9.
To evaluate the role of cytokines in patients with aplastic anemia, colony stimulating activities (CSA) and interferon-gamma (IFN-gamma) in cultured media of lymphocytes with phytohemagglutinin (PHA-LCM) were measured with methylcellulose culture method in 20 patients (age 3 to 69 years). The CSA for granulocyte/macrophage (GM-CSA) in patients was equivalent to that of normal donors, while low burst promoting activity (BPA) was observed in PHA-LCM from 7 adult patients (61 +/- 17%). The ability of BPA production varied widely in 13 children (97 +/- 37%). In some patients, low production of BPA improved after successful treatment of antilymphocyte globulin. The IFN-gamma in PHA-LCM disclosed no significant difference between patients and normal donors. From these results, low production of BPA may have a role in the development of AA in certain patients. It is also suggested that therapy with recombinant cytokines such as GM-CSF and IL-3, detected as BPA in our culture system, could be effective for those patients.
为评估细胞因子在再生障碍性贫血患者中的作用,采用甲基纤维素培养法对20例患者(年龄3至69岁)淋巴细胞经植物血凝素刺激后的培养基中的集落刺激活性(CSA)和干扰素-γ(IFN-γ)进行了检测。患者的粒细胞/巨噬细胞集落刺激活性(GM-CSA)与正常供者相当,但在7例成年患者(61±17%)的植物血凝素刺激淋巴细胞培养基(PHA-LCM)中观察到低爆式促进活性(BPA)。13例儿童患者的BPA产生能力差异很大(97±37%)。在一些患者中,抗淋巴细胞球蛋白成功治疗后BPA的低产生情况有所改善。PHA-LCM中的IFN-γ在患者和正常供者之间无显著差异。从这些结果来看,BPA的低产生可能在某些患者再生障碍性贫血的发生中起作用。还提示,在我们的培养系统中作为BPA检测到的重组细胞因子如粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素-3(IL-3)治疗可能对这些患者有效。